ACQUISITION OF NON-CATALOGED MEDICINES GROUP B (BLOOD AND BLOOD-FORMING ORGANS) FIRST QUARTER - 2025 PROGRAMMING. - PHARMACY AND THERAPEUTICS COMMITTEE MINUTES 002 – 2025

This tender concerns the acquisition of non-cataloged medicines, specifically within Group B, which includes blood and blood-forming organs. The procurement is scheduled for the first quarter of 2025, as detailed in the Pharmacy and Therapeutics Committee Minutes 002 of 2025. The contracting entity is the CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA "MARIA ROSA PARRA ARREAGA" (CCQA-HD SAMBORONDON). The specific item required under this tender is Tranexamic Acid, a parenteral liquid solution with a concentration of 100 mg/mL, supplied in boxes containing 5 mL ampoules. The quantity requested is 100 units, with an estimated value of USD 99,376.80. The procurement method specified is Electronic Reverse Auction (Subasta Inversa Electrónica). This process aims to secure essential medical supplies for the Samborondón clinic, ensuring the availability of critical medications for patient treatment during the initial period of 2025. The focus on non-cataloged items suggests a need for specialized or less commonly stocked pharmaceuticals. Interested suppliers are expected to meet the technical specifications for Tranexamic Acid and adhere to the procedures of the electronic reverse auction to be considered for this contract.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 99,377.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.